Physician profile
Joann Ahern
NPI 1770566317
$35,397.42
in general payments reported to CMS, 2019-2025
9 companies · $278 in 2025
The $278 reported for 2025 was more than what 79% of Medical-Surgical (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,183 · 2022: $12K · 2023: $7,610 · 2024: $7,616 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,400.00 |
| Food and Beverage | $1,104.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $34,243.62 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $321.14 | 2022-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $314.55 | 2021-2025 | Afrezza |
| Dexcom, INC. | $168.50 | 2023 | Dexcom G7 Gss (161) |
| Insulet Corporation | $160.44 | 2022-2024 | Omnipod |
| Lilly USA, LLC | $118.94 | 2022-2024 | Baqsimi, Lyumjev |
| Zealand Pharma US, INC. | $39.30 | 2021 | |
| Novo Nordisk INC | $19.03 | 2022 | |
| Xeris Pharmaceuticals, INC. | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Ahern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.